• -$5.00
  • New
ARA-290 Powerock Pharma vial 10mg, research peptide, laboratory vial, label CAS 1238214-44-3, research use only

Powerock Pharma ARA-290 10 mg

Last price of 30 days: 0,00
$45.90
$40.90 Save $5.00
Tax included

Powerock Pharma delivers results and pure ARA-290, which supports nervous system regeneration through the activation of the innate repair receptor (IRR) to rebuild small nerve fibers while simultaneously reducing inflammation, ensuring effective neuroprotection without affecting hematopoietic parameters.

In Stock
Quantity

ARA-290 (CIBINETIDE) 10 mg

ARA-290 (Cibinetide) is an advanced, high-purity research peptide designed for experimental purposes in the field of nervous system regeneration and inflammation reduction. This compound is an innovative derivative of erythropoietin (EPO). It was developed for effective research on neuroprotection, neuropathy, and tissue repair processes. Its unique mechanism of action is based on the selective activation of the innate repair receptor (IRR), allowing for the stimulation of regeneration without affecting the hematopoietic system. This specific property makes ARA-290 widely applicable in research regarding small nerve fiber regeneration, diabetes, and autoimmune diseases.

ARA-290 Powerock Pharma - Properties

Discover the potential laboratory properties of ARA-290 that may support research on nerve connection reconstruction, inflammation suppression, and cellular homeostasis.

🧠

Nerve Regeneration

Supports repair processes of small nerve fibers and neuronal structures in injury models.

🛡️

Strong Cytoprotection

Protects cells against apoptosis and oxidative stress under laboratory conditions.

🔥

Inflammation Reduction

Effectively suppresses inflammatory reactions by inhibiting pro-inflammatory cytokines.

🎯

Precise Action (IRR)

Selectively binds to the repair receptor (IRR) activated only in damaged tissues.

🩸

Hematological Safety

Does not stimulate red blood cell production, eliminating the risk of blood thickening in research.

🧬

Metabolic Support

Shows potential in research models related to diabetes and glucose metabolism.

🧪

High Purity

≥98% peptide purity confirmed by HPLC/MS method for result reliability.

🔬

Research Quality

Manufactured according to GMP, HACCP, and ISO 13485 standards exclusively for scientific purposes.

How ARA-290 Works (Research Mechanism)

  • IRR Receptor Activation: ARA-290 selectively triggers the signaling pathway of the innate repair receptor, initiating healing processes.
  • Analgesic Effect: In neuropathy models, a reduction in pain signals is observed through the modulation of nerve inflammation.
  • Nerve Fiber Reconstruction: Promotes growth and density of nerve fibers in skin and peripheral tissues.
  • Immune System Modulation: Reduces the activity of pro-inflammatory macrophages, restoring tissue balance.
  • No Hematopoietic Effect: Unlike EPO, it does not affect hematocrit, allowing for safe long-term research observations.

Why Choose ARA-290 from Powerock Pharma?

At Powerock Pharma, our priority is to provide only the highest quality research reagents. Every batch of ARA-290 is manufactured in laboratories compliant with GMP, HACCP, and ISO 13485 standards. Our strict quality control supervision and use of state-of-the-art testing procedures (HPLC, MS) ensure not only the effectiveness of the research material but also its stability and reliability. Cooperation with leading laboratories to ensure purity ≥98% and precise concentration of substances ensures lasting and reproducible experimental results. By choosing Powerock Pharma, you are betting on excellence, procedural safety, and unmatched quality of scientific research materials.

Research Protocol

💉
Application Method:

ARA-290 is a lyophilized peptide intended for reconstitution. In a laboratory setting, subcutaneous injection (s.c.) is most commonly used to ensure optimal bioavailability.

Dosing Frequency:

Due to the peptide's short half-life, daily application is recommended to maintain continuity of action in the research model.

📅
Cycle Duration:

The standard research cycle for ARA-290 ranges from 4 to 12 weeks. This period allows for the observation of nerve fiber regeneration and documentation of anti-inflammatory effects.

🔬
Recommended Reagent Amount for Model A:

In studies on Model A (e.g., lower body mass), a research dose of 2 mg – 4 mg daily is typically used, adjusted to the experiment's objective.

⚗️
Recommended Reagent Amount for Model B:

For Model B (e.g., standard adult model), the reference dose hovers around 4 mg daily. The amount may be modified depending on the severity of neuropathy in the model.

💡
Monitoring:

Continuous monitoring of inflammatory markers and reactions to stimuli in test subjects is essential. Progress in tissue regeneration must be recorded throughout the duration of the protocol.

Frequently Asked Questions

What is the standard dose for research purposes?
  • Most research protocols suggest using a dose of 4 mg daily administered subcutaneously. This dose ensures optimal saturation of IRR receptors without inducing systemic effects unrelated to the study goal.
Can this reagent be combined with other peptides (Stacking)?
  • Yes, in research, ARA-290 is often combined with BPC-157 (systemic regeneration), TB-500 (tissue healing), or Semax (cognitive functions and neurotrophic effects) to achieve synergistic effects in nervous system regeneration.
What are the storage conditions for the product?
  • The product in lyophilized form (powder) should be stored at 2–8°C (refrigerator), away from light. Once reconstituted, the solution is unstable and should be kept under refrigeration and used within a short time.
Does the product show adverse effects in research models?
  • ARA-290 is characterized by a high safety profile. Unlike erythropoietin, it does not cause an increase in hematocrit or blood thickening. Mild reactions at the injection site are rarely observed.
How is the quality of Powerock Pharma products confirmed?
  • Our reagents are produced according to GMP/ISO standards. Purity ≥98% is verified by high-performance liquid chromatography (HPLC) and mass spectrometry (MS), ensuring no impurities that could affect the study result.

Calculator for measuring research doses

Tip: 1 MG = 1000 MCG

Syringe Capacity
Number of Units on the Syringe
ui
Amount of Peptide in the Vial
MG
Expected Peptide Dose per Serving
MCG
Amount of Liquid (water/saline) added to the peptide vial
ML

Related Products ( 16 other products in the same category )